Global 24 Hours Ambulatory Blood Pressure Monitor Market Size By Type (OrdinaryABPM, Mobile-basedABPM), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global 24 Hours Ambulatory Blood Pressure Monitor Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 2.3 billion by 2031, expanding at a CAGR of 9.4% from 2023 to 2031. The market is experiencing robust growth driven by the increasing prevalence of hypertension and cardiovascular disorders, a shift toward continuous blood pressure monitoring, and the adoption of mobile health technologies. Ambulatory blood pressure monitors (ABPMs), which measure blood pressure at regular intervals over 24 hours, offer superior accuracy compared to traditional methods, making them essential for diagnosing white-coat and masked hypertension.

Drivers:

1. Growing Incidence of Hypertension:

The rise in lifestyle-related conditions, such as obesity, stress, and poor dietary habits, has resulted in an increased global prevalence of hypertension. ABPMs enable accurate, real-time blood pressure monitoring, facilitating early diagnosis and effective treatment.

2. Shift Toward Preventive Healthcare:

Governments and healthcare providers are increasingly emphasizing preventive diagnostics. ABPMs are pivotal in monitoring and managing hypertension before complications arise, enhancing patient outcomes and reducing long-term healthcare costs.

3. Technological Advancements in Wearable Health Devices:

Modern ABPM devices now integrate features such as Bluetooth connectivity, cloud-based analytics, and smartphone compatibility, boosting user engagement and facilitating remote monitoring, which supports broader healthcare digitization trends.

Restraints:

1. High Cost and Limited Reimbursement Policies:

The high upfront cost of ABPMs and lack of comprehensive insurance reimbursement in some regions can hinder adoption, especially in low- and middle-income countries.

2. Patient Discomfort and Compliance Issues:

Wearing a device for 24 hours may cause discomfort or disrupt daily activities and sleep, impacting patient compliance and data accuracy.

Opportunity:

1. Expansion into Emerging Markets:

Rapid urbanization, rising disposable incomes, and growing awareness of chronic diseases in Asia-Pacific, Latin America, and Africa present untapped opportunities for ABPM manufacturers.

2. Integration with Telemedicine and AI Analytics:

The growing adoption of telemedicine opens avenues for integrating ABPM data with AI-driven platforms to provide predictive insights and personalized treatment strategies.

Market by System Type Insights:

The wrist-worn ABPM segment held the largest market share in 2023 due to its convenience and ease of use, especially for elderly patients. However, arm-cuff ABPMs are gaining popularity in clinical settings due to their higher accuracy and data reliability. The increasing demand for user-friendly and portable monitoring solutions is expected to propel both segments during the forecast period.

Market by End-use Insights:

Hospitals and Clinics were the leading end-users in 2023, accounting for over 45% of the market share. The integration of ABPMs in outpatient diagnostic procedures and hypertension management programs supports this trend. Meanwhile, the home healthcare segment is witnessing the fastest growth, driven by remote monitoring needs and the rising geriatric population.

Market by Regional Insights:

North America dominated the global 24 Hours Ambulatory Blood Pressure Monitor market in 2023, supported by advanced healthcare infrastructure, favorable reimbursement scenarios, and high awareness of cardiovascular diseases. Asia-Pacific is projected to witness the fastest growth through 2031, spurred by rising health awareness, increasing medical device penetration, and supportive government initiatives.

Competitive Scenario:

Leading players in the global 24 Hours Ambulatory Blood Pressure Monitor Market include Spacelabs Healthcare, Welch Allyn (Hillrom), Microlife Corporation, Schiller AG, Contec Medical Systems, Omron Healthcare, BPL Medical Technologies, and SunTech Medical. These companies are focusing on technological innovation, strategic partnerships, and regional expansion to capture market share.

Key Developments:

In 2023, Spacelabs Healthcare launched a new ABPM model with AI-enabled analytics and smartphone integration.

In 2024, Microlife expanded its distribution in Southeast Asia to meet rising regional demand.

In 2025, Welch Allyn unveiled a compact ABPM device tailored for pediatric hypertension screening.

Scope of Work – Global 24 Hours Ambulatory Blood Pressure Monitor Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 2.3 billion

CAGR (2023–2031) 9.4%

Key Segments by System Type Wrist-worn, Arm-cuff

Key Segments by End-use Hospitals & Clinics, Home Healthcare

Leading Region North America

Key Players Spacelabs, Omron, Microlife, Welch Allyn

Growth Drivers Hypertension prevalence, wearable tech advances

Opportunities Emerging markets, AI & telemedicine integration

FAQs:

1. What is the current market size of the Global 24 Hours Ambulatory Blood Pressure Monitor Market?

The market size in 2023 was valued at USD 1.1 billion.

2. What is the major growth driver of the Global 24 Hours Ambulatory Blood Pressure Monitor Market?

The key driver is the rising global prevalence of hypertension and the need for accurate, continuous monitoring solutions.

3. Which is the largest region during the forecast period in the Global 24 Hours Ambulatory Blood Pressure Monitor Market?

North America is expected to dominate the market due to advanced healthcare systems and high adoption of diagnostic technologies.

4. Which segment accounted for the largest market share in Global 24 Hours Ambulatory Blood Pressure Monitor Market?

The wrist-worn ABPM segment accounted for